Good Medicine Podcast

A recent study is raising important questions about the relationship between anemia and cancer.

In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss discuss new findings from the Karolinska Institute in Sweden that suggest a significant increase in cancer diagnoses shortly after the onset of anemia.

They explore what “incident anemia” means, why iron deficiency is the most common cause, and the many possible reasons someone may become anemic.

The conversation also highlights how to interpret risk. While the relative increase may be high, understanding what that means in absolute terms is critical for context.

This episode breaks down the data, what it may signal, and why changes in the body should not be ignored.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: https://www.instagram.com/good.medicine.podcast/

X: https://x.com/GoodMedicinePod

TikTok: https://www.tiktok.com/@good.medicine.podcast

LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Brain injury is often misunderstood as damage to neurons alone. The reality is far more complex.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Donna Cross to discuss her journey into building a company focused on treating brain-related diseases and the science behind her work.

Dr. Cross shares how a personal connection to Alzheimer’s through a donor to her lab reinforced her commitment to advancing this field and pushed her to take her work beyond academia.

The conversation also explores how brain injury affects multiple systems at once, including the vasculature, the blood-brain barrier, and inflammatory pathways, and why understanding this complexity is critical for developing effective therapies.

Finally, they discuss a broader shift in drug development toward mechanism-based platforms, where therapies are designed to target underlying biological processes rather than a single disease.

Topics covered include:

• The real impact of brain injury beyond neurons• The connection between brain injury and neurodegenerative disease• The shift toward mechanism-based drug development

🎧 Listen on Spotify and Apple Podcasts📺 Subscribe for more conversations on science, medicine, and innovation.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/X: https://x.com/GoodMedicinePodTikTok: https://www.tiktok.com/@good.medicine.podcastLinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Pelvic floor disorders affect millions of women, yet many struggle to find effective treatment.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Gabi Niederauer, founder of Freyya, to discuss her journey and the work her team is doing to improve women’s health.

Freyya has developed a device designed to help women perform pelvic floor therapy exercises correctly by providing real-time feedback. Pelvic floor therapy is often prescribed, but many women are unsure if they are doing the exercises properly, which can limit results.

Dr. Niederauer explains the symptoms of pelvic floor disorders, why they are more common than many people realize, and how new technology may help improve outcomes.

This conversation highlights an area of medicine that is often overlooked, despite affecting a significant portion of the population.

Topics covered include:

• The symptoms and prevalence of pelvic floor disorders

• Why pelvic floor therapy can be difficult to perform correctly

• How real-time feedback may improve treatment outcomes

🎧 Listen on YouTube and Apple Podcasts

📺 Subscribe for more conversations on science, medicine, and innovation.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: https://www.instagram.com/good.medicine.podcast/

X: https://x.com/GoodMedicinePod

TikTok: https://www.tiktok.com/@good.medicine.podcast

LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Freyya:https://www.linkedin.com/company/freyya https://twitter.com/FreyyaInc https://www.instagram.com/freyyainc/ https://www.facebook.com/profile.php?id=61577886342907Dr. Niederauer:https://www.linkedin.com/in/gabriele-niederauer-phd-87365a11/https://www.instagram.com/gabiniederauer/

Peptides are becoming increasingly popular, but how should we actually think about them?

In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss discuss how peptides fit into the broader landscape of supplements, drugs, and regulation.

They explore why peptides are often treated more like supplements than pharmaceuticals, what that means for safety and effectiveness, and why not all peptides are created equal.

The conversation also covers the current regulatory environment, how it impacts innovation in medicine, and why there is growing discussion around potential changes.

Finally, they discuss an important safety consideration. Introducing substances into the body through injection bypasses many of the body’s natural protective systems, which is something people should think carefully about.

Topics covered include:

• How peptides compare to supplements and pharmaceuticals

• The role of regulation in safety and innovation

• Key safety considerations when using injectable compounds

🎧 Listen on Spotify and Apple Podcasts

📺 Subscribe for more conversations on science, medicine, and innovation.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: https://www.instagram.com/good.medicine.podcast/

X: https://x.com/GoodMedicinePod

TikTok: https://www.tiktok.com/@good.medicine.podcast

LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Alzheimer’s disease has long been defined by cognitive decline. But that way of thinking is changing.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Brendon Boot from S2N to discuss how the field of Alzheimer’s research has evolved from focusing on symptoms to understanding the underlying changes in the brain.

They explore how this shift is influencing regulators, the importance of earlier intervention, and how new therapies could change the way we approach neurodegenerative disease.

Dr. Boot also shares how S2N is using naturally occurring Alzheimer’s in dogs as a model for clinical development, and why this approach may help accelerate progress toward human therapies.

If early results translate to humans, even partially, this work has the potential to significantly impact how Alzheimer’s is treated in the future.

Topics covered include:

• The shift from symptom-based to biology-based understanding of Alzheimer’s

• Why earlier intervention may be critical for treatment success

• Using naturally occurring disease models to advance clinical research

🎧 Listen on Spotify and Apple Podcasts
📺 Subscribe for more conversations on science, medicine, and innovation.

NOTE: Dr. Boot misspoke around 22.50. "going to conferences when Leqembi..." he meant to say "going to conferences when Solanezumab...". He requested this get added to the notes for clarity.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: https://www.instagram.com/good.medicine.podcast/

X: https://x.com/GoodMedicinePod

TikTok: https://www.tiktok.com/@good.medicine.podcast

LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Heart disease remains the leading cause of death worldwide, yet many of the biggest risk factors are preventable.

In this episode of the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Troy Badger from CardioStrong to talk about what actually improves cardiovascular health and what people often get wrong when trying to optimize their health.

They discuss the importance of lifestyle and fitness for reducing cardiovascular risk, the overwhelming amount of health advice circulating on social media, and why simple habits often matter more than complicated protocols.

Dr. Badger shares practical insight from working with patients and athletes on improving long-term health and performance.

Topics covered include:

• Why lifestyle and exercise remain the most powerful tools for heart health• Navigating misinformation in online health advice• The importance of simplicity in maintaining long-term health

🎧 Listen on Spotify and Apple Podcasts📺 Subscribe for more conversations on science, medicine, and innovation.

Dr. Badger LinkedIn: https://www.linkedin.com/in/troy-badger-md-1313975/CardioStrong Website: https://sparchealthutah.org/

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/X: https://x.com/GoodMedicinePodTikTok: https://www.tiktok.com/@good.medicine.podcastLinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Alex Wallberg from SPARC Health to talk about building healthcare startups that actually improve patient outcomes.

SPARC Health focuses on helping technical founders navigate the complex world of healthcare innovation by pairing them with experienced mentors, operators, and capital providers who can guide companies through the challenges of building in life sciences and health technology.

Alex shares how SPARC works with founders to translate promising ideas into real companies, and why mentorship, community, and strategic support are essential for success in healthcare innovation.

The conversation also explores what separates great founders from the rest. Alex emphasizes that the best entrepreneurs keep patients at the center of their mission, while Dr. Bearss notes that when founders focus primarily on money rather than impact, it is often a warning sign.

Finally, Alex reflects on the strength of Utah’s life sciences community and why collaboration between entrepreneurs, investors, and operators has become one of the region’s biggest advantages.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

Alex Wallberg LinkedIn: https://www.linkedin.com/in/alex-wallberg/

SPARC Health LinkedIn: https://www.linkedin.com/company/sparchealth/

SPARC Health Website: https://sparchealthutah.org/

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Evan Unger, physician-scientist, serial biotech entrepreneur, and pioneer in therapeutic oxygen delivery technologies.

Dr. Unger has spent decades working at the intersection of medicine, physics, and innovation. His work has focused on developing technologies that improve how oxygen is delivered to tissues in critical conditions such as cancer and heart attack. Tumor hypoxia, a state where parts of a tumor are deprived of adequate oxygen, has long been recognized as a major barrier to effective radiation therapy. Hypoxic tumors are more resistant to treatment, which can limit outcomes. Dr. Unger discusses why this problem has persisted since it was first described in the 1950s and why he believes his current work may represent one of the first meaningful approaches to reversing tumor hypoxia.

The conversation also explores the realities of being an inventor and biotech founder. Dr. Unger reflects on how having too many ideas can become a liability, and why focus, regulatory strategy, market opportunity, and disciplined value creation are essential for translating innovation into impact.

Finally, he shares why he remains driven by the possibility that new approaches to oxygen delivery could fundamentally transform treatment for heart attack, still the leading cause of death in the United States. This episode is about persistence, disciplined innovation, and pursuing breakthroughs that could change outcomes at scale.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Olympic gold medalist Peter Vidmar to talk about excellence, discipline, and the lifelong impact of exercise.

Peter reflects on his journey to Olympic gold, the influence of a coach who emphasized fundamentals above everything else, and how mastering the basics accelerated his growth. He shares how his love for gymnastics began at a young age and why he never cared whether his peers understood his passion.

The conversation also explores Peter’s work with the “Ready, Set, Gold” program, where Olympians partnered with schools to inspire young people to improve their physical fitness. He discusses the powerful connection between physical activity, mental health, and long-term well-being.

From elite competition to everyday fitness, this episode is about consistency, discipline, and finding movement that works for you.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Myles Greenberg, President and CEO of InCarda Therapeutics, to explore the non-traditional path from practicing physician to life sciences executive.

With more than 25 years of experience across clinical medicine, venture capital, entrepreneurship, and executive leadership, Dr. Greenberg shares how operating under uncertainty in the emergency room directly prepared him for leading companies through high-stakes decision making.

They discuss the realities of clinical trial execution, the challenges of recruiting patients in acute care settings, and why innovation in medicine remains one of the most demanding yet rewarding fields to work in.

This episode is about resilience, adaptability, and the drive to solve unmet patient needs at scale.

Thank you to our sponsors

BioHive: https://www.biohive.com

Galvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine Podcast

Insta: ⁠https://www.instagram.com/good.medicine.podcast/⁠

X: ⁠https://x.com/GoodMedicinePod⁠

TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠